Skip to main content
SpringerLink
Log in

Les scores endoscopiques des MICI

Endoscopical scoring of inflammatory bowel diseases (IBD)

  • Technique / Technique
  • Published:
Côlon & Rectum

Résumé

L’examen endoscopique est une référence dans la prise en charge des maladies inflammatoires chroniques intestinales (MICI). Il sert à poser le diagnostic mais également à évaluer l’évolutivité de la maladie. Il est donc important de connaître et d’utiliser les scores simples et reproductibles. Si le CDEIS nécessite un certain apprentissage, le score de Rutgeerts, évaluant la récidive iléale après résection iléocolique et guidant l’attitude thérapeutique, est simple et doit être largement diffusé.

Abstract

Endoscopy is the gold standard for IBD diagnosis and care, but also for assessing the evolution of the disease. It is therefore essential to know and to use simple, reproducible scores. Although the CDEIS requires a certain amount of training to use, the postoperative recurrence Rutgeerts score easy to perform and providing validated and reproducible information for choice of treatment, should be widely used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Baron JH, Connell AM, Lennard-Jones JE (1964) Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1:89–92

    Article  PubMed  CAS  Google Scholar 

  2. Rutgeerts P, Sandborn WJ, Feagan BG, et al (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462–2476

    Article  PubMed  CAS  Google Scholar 

  3. Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerativecolitis. A randomized study. N Engl J Med 317:1625–1629

    PubMed  CAS  Google Scholar 

  4. Powell-Tuck J, Day DW, Buckell NA, et al (1982) Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 27:533–537

    Article  PubMed  CAS  Google Scholar 

  5. Rachmilewitz D (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 298:82–86

    Article  PubMed  CAS  Google Scholar 

  6. Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 2:1041–1048

    Article  PubMed  CAS  Google Scholar 

  7. Alemayehu G, Jarneröt G (1991) Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol 86:187–190

    PubMed  CAS  Google Scholar 

  8. Carbonnel F, Lavergne A, Lemann M, et al (1994) Colonoscopy for acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 39:1550–1557

    Article  PubMed  CAS  Google Scholar 

  9. Carbonnel F, Gargouri D, Lémann M, et al (2000) Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 14:273–279

    Article  PubMed  CAS  Google Scholar 

  10. Nahon S, Bouhnik Y, Lavergne-Slove A (2002) Colonoscopy accurately predicts the anatomical severity of colonic Crohn’s disease attacks: correlation with findings from colectomy specimens. Am J Gastroenterol 97:3102–3107

    Article  PubMed  Google Scholar 

  11. Mary JY, Modigliani R (1989) Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’études thérapeutiques des affections inflammatoires du tube digestif (GETAID). Gut 30:983–989

    Article  PubMed  CAS  Google Scholar 

  12. Modigliani R, Mary JY, GETAID (1987) Reproducibility of colonoscopic findings in Crohn’s disease: a prospective multicenter study of interobserver variation. Dig Dis Sci 32:1370–1379

    Article  Google Scholar 

  13. Sandborn WJ, Feagan BG, Hanauer SB, et al (2002) A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology 122:512–530

    Article  PubMed  Google Scholar 

  14. Landi B, Anh TN, Cortot A, et al (1992) Endoscopic monitoring of Crohn’s disease treatment: a prospective, randomized clinical trial. The Groupe d’études thérapeutiques des affections inflammatoires du tube digestif (GETAID). Gastroenterology 102:1647–1653

    PubMed  CAS  Google Scholar 

  15. D’Haens G, Van Deventer S, Van Hogezand R, et al (1999) Endoscopic and histological healing with infliximab antitumor necrosis factor antibodies in Crohn’s disease: a European multicenter trial. Gastroenterology 116:1029–1034

    Article  PubMed  Google Scholar 

  16. Mary JY, Lemann M, Colombel JF, et al (2009) Endoscopic remission and response in Crohn’s disease: an objective definition using the CDEIS. Eur J Gastroenterol Hepatol (in press)

  17. Rutgeerts P, Diamond RH, Bala M, et al (2006) Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s disease. Gastrointest Endosc 63:433–442

    Article  PubMed  Google Scholar 

  18. D’Haens G, Van Deventer S, Van Hogezand R, et al (1999) Endoscopic and histological healing with infliximab antitumor necrosis factor antibodies in Crohn’s disease: A European multicenter trial. Gastroenterology 116:1029–1034

    Article  PubMed  Google Scholar 

  19. Daperno M, D’Haens G, Van Assche G, et al (2004) Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 60(4):505–512

    Article  PubMed  Google Scholar 

  20. Sachar DB (1990) The problem of postoperative recurrence of Crohn’s disease. Med Clin North Am 71:183–188

    Google Scholar 

  21. Schivananda S, Hordjik ML, Pena AS, Mayberry JF (1989) Crohn’s disease: risk of recurrence and reoperation in a defined population. Gut 30:990–995

    Article  Google Scholar 

  22. Whelan G, Farmer RG, Fazio VW, Goormastic M (1985) Recurrence after surgery in Crohn’s disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 88:1826–1833

    PubMed  CAS  Google Scholar 

  23. Rutgeerts P, Geboes K, Vantrappen G, et al (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963

    PubMed  CAS  Google Scholar 

  24. Rutgeerts P, Van Assche G, Vermeire S, et al (2005) Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double blind, placebo-controlled trial. Gastroenterology 128:856–861

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pôle des maladies de l’appareil digestif (PMAD), gastroentérologie et assistance nutritive, hôpital Beaujon, 100, boulevard du Général-Leclerc, F-92110, Clichy, France

    Y. Bouhnik, A. Attar & X. Treton

Authors
  1. Y. Bouhnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Attar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X. Treton
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Bouhnik, Y., Attar, A. & Treton, X. Les scores endoscopiques des MICI. Colon Rectum 3, 101–106 (2009). https://doi.org/10.1007/s11725-009-0151-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11725-009-0151-y

Mots clés

Keywords

Search

Navigation